Unicycive Therapeutics UNCY
NASDAQ UNCY
$3.78 +0.12 (+3.28%)
At close: Nov 11, 2026 · 4:00 PM EST

Unicycive Therapeutics (UNCY) Preferred Stock Liabilities (2023 - 2024)

Updated

Unicycive Therapeutics (UNCY) reported Preferred Stock Liabilities of $46.19 million for Q2 2024, up 76.3% from $26.2 million a year earlier and unchanged from the prior quarter.

Analysis

Unicycive Therapeutics (UNCY) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends

Dating back to Q1 2023, Unicycive Therapeutics' Preferred Stock Liabilities record includes 4 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Unicycive Therapeutics 101.95 Mn -98.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 46.19 Mn
Mar 31, 2024 46.19 Mn
Sep 30, 2023 44,000.00
Jun 30, 2023 26.20 Mn
Mar 31, 2023 25.60 Mn
API Access

Unicycive Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=UNCY&period=max&api_key=YOUR_API_KEY